EXPONENT INCEXPOEarnings & Financial Report
Exponent, Inc. is an American engineering and scientific consulting firm. Exponent has a team of scientists, physicians, engineers, and business consultants which performs research and analysis in more than 90 technical disciplines. The company operates 20 offices in the United States and five offices overseas.
EXPO Q1 FY2027 Key Financial Metrics
Revenue
$166.3M
Gross Profit
N/A
Operating Profit
$41.4M
Net Profit
$29.6M
Gross Margin
N/A
Operating Margin
24.9%
Net Margin
17.8%
YoY Growth
14.3%
EPS
$0.59
EXPONENT INC Q1 FY2027 Financial Summary
EXPONENT INC reported revenue of $166.3M (up 14.3% YoY) for Q1 FY2027, with a net profit of $29.6M (up 11.0% YoY) (17.8% margin).
Key Financial Metrics
| Total Revenue | $166.3M |
|---|---|
| Net Profit | $29.6M |
| Gross Margin | N/A |
| Operating Margin | 24.9% |
| Report Period | Q1 FY2027 |
Revenue Breakdown
EXPONENT INC Q1 FY2027 revenue of $166.3M breaks down across 2 segments, led by Revenues before reimbursements at $151.8M (91.3% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Revenues before reimbursements | $151.8M | 91.3% |
| Reimbursements | $14.5M | 8.7% |
EXPONENT INC Revenue by Segment — Quarterly Trend
EXPONENT INC revenue by segment across the last 4 reported quarters, showing how each business line (such as Revenues before reimbursements and Reimbursements) has evolved quarter over quarter.
| Segment | Q1 FY2027 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|
| Revenues before reimbursements | $151.8M | $129.4M | — | — |
| Reimbursements | $14.5M | $18.0M | — | — |
EXPONENT INC Annual Revenue by Year
EXPONENT INC annual revenue history includes year-by-year totals (for example, 2025 revenue was $582.0M).
EXPONENT INC Quarterly Revenue & Net Profit History
EXPONENT INC results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2027 | $166.3M | +14.3% | $29.6M | 17.8% |
| Q4 FY2025 | $147.4M | +7.8% | $24.8M | 16.8% |
| Q3 FY2025 | $147.1M | +8.0% | $28.0M | 19.1% |
| Q2 FY2025 | $142.0M | +1.0% | $26.6M | 18.7% |
| Q1 FY2025 | $145.5M | +0.4% | $26.6M | 18.3% |
| Q4 FY2024 | $136.8M | +11.3% | $23.6M | 17.2% |
| Q3 FY2024 | $136.3M | +2.2% | $26.0M | 19.1% |
| Q2 FY2024 | $140.5M | +0.2% | $29.2M | 20.8% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2027 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $140.5M | $136.3M | $136.8M | $145.5M | $142.0M | $147.1M | $147.4M | $166.3M |
| YoY Growth | 0.2% | 2.2% | 11.3% | 0.4% | 1.0% | 8.0% | 7.8% | 14.3% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2027 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $709.2M | $744.1M | $777.3M | $763.2M | $759.4M | $761.4M | $777.5M | $687.4M |
| Liabilities | $316.0M | $333.8M | $356.2M | $321.8M | $331.7M | $358.6M | $387.2M | $349.0M |
| Equity | $393.2M | $410.3M | $421.1M | $441.4M | $427.8M | $402.9M | $390.3M | $338.3M |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|
| Operating CF | $48.3M | $29.7M | $56.1M | $7.3M | $36.2M | $32.7M |